NeueHealth, Inc.
NEUE
$6.73
$0.010.15%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 63.35M | 71.79M | 64.11M | 61.67M | 60.16M |
| Total Other Revenue | 169.29M | 161.14M | 161.88M | 183.43M | 232.71M |
| Total Revenue | 232.64M | 232.93M | 225.99M | 245.10M | 292.87M |
| Cost of Revenue | 184.89M | 182.69M | 177.68M | 196.87M | 264.86M |
| Gross Profit | 47.75M | 50.24M | 48.31M | 48.22M | 28.01M |
| SG&A Expenses | 69.59M | 64.08M | 70.23M | 66.82M | 69.49M |
| Depreciation & Amortization | 3.60M | 3.50M | 3.98M | 4.56M | 4.03M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 258.08M | 250.28M | 251.89M | 268.26M | 338.38M |
| Operating Income | -25.44M | -17.34M | -25.90M | -23.16M | -45.51M |
| Income Before Tax | -43.15M | -23.21M | -39.45M | 6.35M | -61.24M |
| Income Tax Expenses | -672.00K | 2.79M | -187.00K | 663.00K | 1.59M |
| Earnings from Continuing Operations | -42.48M | -26.01M | -39.26M | 5.69M | -62.83M |
| Earnings from Discontinued Operations | 45.00M | -14.36M | -18.44M | -9.87M | -397.75M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -5.25M | -17.05M | -932.00K | -11.74M | 230.86M |
| Net Income | -2.72M | -57.41M | -58.63M | -15.91M | -229.72M |
| EBIT | -25.44M | -17.34M | -25.90M | -23.16M | -45.51M |
| EBITDA | -21.84M | -13.84M | -21.92M | -18.60M | -35.62M |
| EPS Basic | -1.94 | -8.51 | -8.65 | -3.53 | -30.47 |
| Normalized Basic EPS | -3.61 | -3.81 | -2.22 | -3.31 | 24.25 |
| EPS Diluted | -1.94 | -8.51 | -8.65 | -3.53 | -30.47 |
| Normalized Diluted EPS | -3.61 | -3.81 | -2.22 | -3.31 | 24.25 |
| Average Basic Shares Outstanding | 8.23M | 8.28M | 8.25M | 8.08M | 7.95M |
| Average Diluted Shares Outstanding | 8.23M | 8.28M | 8.25M | 8.08M | 7.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |